Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$1.94
Net Income/Share$-0.05
Operating CF/Share$0.04
Free CF/Share$0.03
Cash/Share$0.86
Book Value/Share$0.75
Tangible Book/Share$0.06
Equity/Share$0.75
Interest Debt/Share$1.59
CapEx/Share$0.01
Dividend/Share$0.00
Valuation
Market Cap$4.48B
Enterprise Value$4.74B
P/E Ratio-313.49P/S Ratio7.49P/OCF Ratio339.71
P/FCF Ratio462.58
P/B Ratio19.13P/TB Ratio19.13
EV/Sales7.91EV/EBITDA79.88
Graham Valuation
Graham Number--
Graham Net-Net$-0.65
Profitability
Earnings Yield-0.32%FCF Yield0.22%ROE-6.84%ROIC-13.65%Return on Tangible Assets-2.14%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF25.32%
CapEx/Revenue0.55%
CapEx/Depreciation0.43
SBC/Revenue13.37%
SG&A/Revenue0.00%
R&D/Revenue23.77%
Liquidity & Solvency
Debt/Equity1.92Debt/Assets0.51Debt/Market Cap0.10
Net Debt/EBITDA4.26
Current Ratio2.99Interest Coverage0.70xIncome Quality-0.92Efficiency
Days Sales Outstanding69 days
Days Payables Outstanding111 days
Days Inventory1029 days
Receivables Turnover5.26x
Payables Turnover3.30x
Inventory Turnover0.35x
Capital Structure
Tangible Assets$17.88M
Working Capital$395.14M
Invested Capital$656.98M
Intangibles/Assets24.46%